Elizabeth J. Bradbury

Elizabeth J. Bradbury

Auto-generated profile, based on publicly available information

Elizabeth J. Bradbury

The Wolfson Centre for Age-Related Diseases, King’s College London

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2002 in Nature
Verified
Journal Article
Closed access
EBElizabeth J. Bradbury
Elizabeth J. Bradbury
LMLawrence Moon
Lawrence Moon
RPReena J. Popat
Reena J. Popat
VKVon R. King
Von R. King
GBGavin S. Bennett
Gavin S. Bennett
SMStephen B. McMahon
Stephen B. McMahon

28 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
EBElizabeth J. Bradbury
Elizabeth J. Bradbury
EBEmily R. Burnside
Emily R. Burnside
Traumatic spinal cord injury results in severe and irreversible loss of function. The injury triggers a complex cascade of inflammatory and pathological processes, culminating in formation of a scar. While traditionally referred to as a glial scar, the spinal injury scar in fact comprises multiple cellular and extracellular components. This multidimensional nature should be considered when aiming to understand the role of scarring in limiting tissue repair and recovery. In this Review we discuss recent advances in understanding the composition and phenotypic characteristics of the spinal injury scar, the oversimplification of defining the scar in binary terms as good or bad, and the development of therapeutic approaches to target scar components to enable improved functional outcome after spinal cord injury.

1 November 1998 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
EBElizabeth J. Bradbury
Elizabeth J. Bradbury
GBGeoffery Burnstockb
Geoffery Burnstockb
SMStephen B. McMahon
Stephen B. McMahon

20 March 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
Emad MoeendarbaryEmad Moeendarbary
Emad Moeendarbary
IWIsabell P. Weber
Isabell P. Weber
GSGraham K. Sheridan
Graham K. Sheridan
DKDavid E. Koser
David E. Koser
SSSara Soleman
Sara Soleman
FKFranze Kristian
Franze Kristian
Injury to the central nervous system (CNS) alters the molecular and cellular composition of neural tissue and leads to glial scarring, which inhibits the regrowth of damaged axons. Mammalian glial scars supposedly form a chemical and mechanical barrier to neuronal regeneration. While tremendous effort has been devoted to identifying molecular characteristics of the scar, very little is known about its mechanical properties. Here we characterize spatiotemporal changes of the elastic stiffness of the injured rat neocortex and spinal cord at 1.5 and three weeks post-injury using atomic force microscopy. In contrast to scars in other mammalian tissues, CNS tissue significantly softens after injury. Expression levels of glial intermediate filaments (GFAP, vimentin) and extracellular matrix components (laminin, collagen IV) correlate with tissue softening. As tissue stiffness is a regulator of neuronal growth, our results may help to understand why mammalian neurons do not regenerate after injury.

15 June 1999 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
BKB. J. Kerr
B. J. Kerr
EBE. J. Bradbury
E. J. Bradbury
DBD. L. H. Bennett
D. L. H. Bennett
PTP. M. Trivedi
P. M. Trivedi
PDP. Dassan
P. Dassan
STS. W. N. Thompson
S. W. N. Thompson
Central sensitization, the hyperexcitability of spinal processing that often accompanies peripheral injury, is a major component of many persistent pain states. Here we report that the neurotrophin, brain-derived neurotrophic factor (BDNF), is a modulator of excitability within the spinal cord and contributes to the mechanism of central sensitization. BDNF, localized in primary sensory neuron cell bodies and central terminals, potentiates nociceptive spinal reflex responses in anin vitrospinal cord preparation and induces c-fos expression in dorsal horn neurons. NMDA receptor-mediated responses, known as a major contributor to central sensitization, were significantly enhanced by exogenous BDNF. Systemic NGF treatment, a procedure that mimics peripheral inflammatory states, raises BDNF levels in sensory neurons and increases nociceptive spinal reflex excitability. This increased central excitability is reduced by trkB-IgG, a BDNF “antagonist.” We also show directly that inflammatory pain-related behavior depends on BDNF releasein vivo. Thus behavioral nociceptive responses induced by intraplantar formalin and by intraplantar carageenan are significantly attenuated by trkB-IgG. Hence BDNF is appropriately localized and regulated in inflammatory states and is sufficient and necessary for the expression of central sensitization in the spinal cord. We propose that BDNF may function as a modulator of central sensitization in pathological states, and our results suggest that pharmacological antagonism of BDNF may prove an effective and novel analgesic strategy for the treatment of persistent inflammatory pain states.

18 October 2006 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
ABA. W. Barritt
A. W. Barritt
MDM. Davies
M. Davies
FMF. Marchand
F. Marchand
RHR. Hartley
R. Hartley
JGJ. Grist
J. Grist
EBE. J. Bradbury
E. J. Bradbury
Chondroitin sulfate proteoglycans (CSPGs) are inhibitory extracellular matrix molecules that are upregulated after CNS injury. Degradation of CSPGs using the enzyme chondroitinase ABC (ChABC) can promote functional recovery after spinal cord injury. However, the mechanisms underlying this recovery are not clear. Here we investigated the effects of ChABC treatment on promoting plasticity within the spinal cord. We found robust sprouting of both injured (corticospinal) and intact (serotonergic) descending projections as well as uninjured primary afferents after a cervical dorsal column injury and ChABC treatment. Sprouting fibers were observed in aberrant locations in degenerating white matter proximal to the injury in regions where CSPGs had been degraded. Corticospinal and serotonergic sprouting fibers were also observed in spinal gray matter at and below the level of the lesion, indicating increased innervation in the terminal regions of descending projections important for locomotion. Spinal-injured animals treated with a vehicle solution showed no significant sprouting. Interestingly, ChABC treatment in uninjured animals did not induce sprouting in any system. Thus, both denervation and CSPG degradation were required to promote sprouting within the spinal cord. We also examined potential detrimental effects of ChABC-induced plasticity. However, although primary afferent sprouting was observed after lumbar dorsal column lesions and ChABC treatment, there was no increased connectivity of nociceptive neurons or development of mechanical allodynia or thermal hyperalgesia. Thus, CSPG digestion promotes robust sprouting of spinal projections in degenerating and denervated areas of the spinal cord; compensatory sprouting of descending systems could be a key mechanism underlying functional recovery.